BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10544652)

  • 21. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility and efficacy of fluticasone propionate and salmeterol inhaled from a single inhaler for persistent asthma.
    Mathison DA; Koziol JA
    J Asthma; 2005 Dec; 42(10):829-31. PubMed ID: 16393719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is guideline-defined asthma control achievable?--secondary publication. The Gaining Optimal Asthma ControL (GOAL) Study].
    Pedersen SE
    Ugeskr Laeger; 2005 Sep; 167(38):3595-7. PubMed ID: 16219190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of fluticasone and salmeterol for asthma.
    Med Lett Drugs Ther; 2001 Apr; 43(1102):31-3. PubMed ID: 11309534
    [No Abstract]   [Full Text] [Related]  

  • 27. Lung blood flow must be considered when prescribing a long-acting β2-agonist/inhaled corticosteroid combination.
    Cazzola M; Matera MG
    Chest; 2012 May; 141(5):1134-1136. PubMed ID: 22553257
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative resource utilization in medicaid-eligible patients with asthma treated with fixed-dose fluticasone propionate/salmeterol or fluticasone propionate monotherapy.
    Stanford RH; Riedel AA; Johnson JC; Astry CL
    Clin Ther; 2010 Sep; 32(10):1782-93. PubMed ID: 21194602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Asthma control with the salmeterol-fluticasone-combination disc compared to standard treatment].
    Molitor S; Liefring E; Trautmann M
    Pneumologie; 2005 Mar; 59(3):167-73. PubMed ID: 15756629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmeterol and Fluticasone Propionate in Children with Asthma.
    Nieto A; Mazón Á; Nieto M
    N Engl J Med; 2016 Dec; 375(22):e46. PubMed ID: 27959747
    [No Abstract]   [Full Text] [Related]  

  • 32. Salmeterol and Fluticasone Propionate in Children with Asthma.
    Stempel DA; Szefler SJ; Pascoe SJ
    N Engl J Med; 2016 Dec; 375(22):e46. PubMed ID: 27959746
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bronchial asthma. A combination preparation improves patient compliance].
    MMW Fortschr Med; 2001 Feb; 143(8):51. PubMed ID: 11265544
    [No Abstract]   [Full Text] [Related]  

  • 34. Patient-reported outcomes among omalizumab and salmeterol/fluticasone combination therapy patients.
    Miller DP; Tom G; Rasouliyan L; Chipps B
    J Asthma; 2009 Mar; 46(2):179-85. PubMed ID: 19253127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma.
    Chanez P; Stallaert R; Reznikova E; Bloemen P; Adamek L; Joos G
    Respir Med; 2010 Aug; 104(8):1101-9. PubMed ID: 20452196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler.
    Masoli M; Weatherall M; Ayling J; Williams M; Beasley R
    Respir Med; 2005 May; 99(5):545-52. PubMed ID: 15823450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma.
    Li HT; Zhang TT; Zhou H; Qu XJ; Wu WM; Huang J
    Respiration; 2007; 74(1):33-43. PubMed ID: 17008769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations.
    Matz J; Emmett A; Rickard K; Kalberg C
    J Allergy Clin Immunol; 2001 May; 107(5):783-9. PubMed ID: 11344343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Right and wrong of salmeterol/fluticasone propionate combination].
    Sagara H
    Arerugi; 2006 Jul; 55(7):794-810. PubMed ID: 16883107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.